BACKGROUND AND PURPOSE: CTA is becoming the frontline modality to reveal aneurysms in patients with SAH. However, in about 20% of SAH patients no aneurysm is found. In these cases, intra-arterial DSA is still performed. Our aim was to evaluate whether negative findings on CTA can reliably exclude aneurysms in patients with acute SAH. MATERIALS AND METHODS: We conducted a retrospective analysis of all negative findings on CTAs performed from 2005 to 2009 in patients with spontaneous SAH. Findings were compared with DSA. CTAs were performed with a 64-section multidetector row CT scanner. RESULTS: One hundred ninety-three patients with SAH and negative findings on CTA who underwent subsequent DSA were identified. The distribution of blood on unenhanced CT was the following: PMH in 93 patients, diffuse aneurysmal pattern in 50, no blood on CT (xanthochromic LP) in 32, and peripheral sulcal distribution in 18. All patients with PMH had negative findings on DSA. One patient with no blood on CT had vasculitis on DSA. Six of 18 (33%) patients with peripheral blood had vasculitis on DSA. Three of these were also diagnosed by CTA. All except 1 patient with diffuse aneurysmal blood had negative findings on DSA. One patient was diagnosed with an aneurysm on DSA (1/50, 0.5%). Repeat delayed DSA performed in 28 of these patients revealed a small aneurysm in 4 (14%). Five patients had a complication of DSA (2.6%); 1 was a clinical stroke (0.5%). CONCLUSIONS: In patients with SAH, negative CTA findings are reliable in ruling out aneurysms in the PMH pattern or no blood on CT. DSA is indicated in the diffuse aneurysmal pattern of SAH, and repeat delayed DSA is required if the initial DSA findings are negative. When the blood is peripheral, CTA should be scrutinized for vasculitis and DSA is recommended for confirmation.
BACKGROUND AND PURPOSE: CTA is becoming the frontline modality to reveal aneurysms in patients with SAH. However, in about 20% of SAHpatients no aneurysm is found. In these cases, intra-arterial DSA is still performed. Our aim was to evaluate whether negative findings on CTA can reliably exclude aneurysms in patients with acute SAH. MATERIALS AND METHODS: We conducted a retrospective analysis of all negative findings on CTAs performed from 2005 to 2009 in patients with spontaneous SAH. Findings were compared with DSA. CTAs were performed with a 64-section multidetector row CT scanner. RESULTS: One hundred ninety-three patients with SAH and negative findings on CTA who underwent subsequent DSA were identified. The distribution of blood on unenhanced CT was the following: PMH in 93 patients, diffuse aneurysmal pattern in 50, no blood on CT (xanthochromic LP) in 32, and peripheral sulcal distribution in 18. All patients with PMH had negative findings on DSA. One patient with no blood on CT had vasculitis on DSA. Six of 18 (33%) patients with peripheral blood had vasculitis on DSA. Three of these were also diagnosed by CTA. All except 1 patient with diffuse aneurysmal blood had negative findings on DSA. One patient was diagnosed with an aneurysm on DSA (1/50, 0.5%). Repeat delayed DSA performed in 28 of these patients revealed a small aneurysm in 4 (14%). Five patients had a complication of DSA (2.6%); 1 was a clinical stroke (0.5%). CONCLUSIONS: In patients with SAH, negative CTA findings are reliable in ruling out aneurysms in the PMH pattern or no blood on CT. DSA is indicated in the diffuse aneurysmal pattern of SAH, and repeat delayed DSA is required if the initial DSA findings are negative. When the blood is peripheral, CTA should be scrutinized for vasculitis and DSA is recommended for confirmation.
Authors: R du Mesnil de Rochemont; W Heindel; C Wesselmann; K Krüger; H Lanfermann; R I Ernestus; M Neveling; K Lackner Journal: Radiology Date: 1997-03 Impact factor: 11.105
Authors: J Pablo Villablanca; Adina Achiriolaie; Parizad Hooshi; Neil Martin; Gary Duckwiler; Reza Jahan; John Frazee; Pierre Gobin; James Sayre; Fernando Viñuela Journal: J Neurosurg Date: 2005-12 Impact factor: 5.115
Authors: J Pablo Villablanca; Reza Jahan; Parizad Hooshi; Silvester Lim; Gary Duckwiler; Aman Patel; James Sayre; Neil Martin; John Frazee; John Bentson; Fernando Viñuela Journal: AJNR Am J Neuroradiol Date: 2002-08 Impact factor: 3.825
Authors: B Lubicz; M Levivier; O François; P Thoma; N Sadeghi; L Collignon; D Balériaux Journal: AJNR Am J Neuroradiol Date: 2007-09-26 Impact factor: 3.825
Authors: Menno R Germans; Bert A Coert; Charles B L M Majoie; René van den Berg; Dagmar Verbaan; W Peter Vandertop Journal: J Neurol Date: 2014-09-03 Impact factor: 4.849
Authors: A Ringelstein; O Mueller; S L Goericke; C Moenninghoff; U Sure; I Wanke; M Forsting; M Schlamann Journal: Clin Neuroradiol Date: 2013-11-28 Impact factor: 3.649
Authors: René van den Berg; Astrid L Rijssenbeek; Marieke E S Sprengers; Joost C J Bot; Charles B L M Majoie; Yvo B W E M Roos; William P Vandertop Journal: Interv Neuroradiol Date: 2014-02-10 Impact factor: 1.610
Authors: J J Heit; G T Pastena; R G Nogueira; A J Yoo; T M Leslie-Mazwi; J A Hirsch; J D Rabinov Journal: AJNR Am J Neuroradiol Date: 2015-09-03 Impact factor: 3.825
Authors: Ramazan Jabbarli; Mukesch Shah; Christian Taschner; Klaus Kaier; Beate Hippchen; Vera Van Velthoven Journal: Neuroradiology Date: 2014-07-24 Impact factor: 2.804